Structure of Dithranol CAS 1143 38 0 - Dithranol CAS 1143-38-0

Iden­ti­fi­ca­tion

CAS Number

1143-38-0

Name

Dithra­nol

Syn­onyms

1,8-Dihydroxy-9(10H)-anthra­cenon [Ger­man] [ACD/IUPAC Name]
1,8-Dihydroxy-9(10H)-anthra­cenone [ACD/IUPAC Name]
1,8-Dihydroxy-9(10H)-anthracénone [French] [ACD/IUPAC Name]
1,8-Dihydroxyanthracen-9(10H)-one
1,8-dihydroxyanthrone
1143-38-0 [RN]
2054360 [Beil­stein]
214-538-0 [EINECS]
9(10H)-Anthra­cenone, 1,8-dihydroxy- [ACD/​Index Name]
Anthralin
dithra­nol [French] [INN]
Dithra­nol [INN] [Wiki]
dithra­nolum [Latin] [INN]
ditra­nol [Span­ish] [INN]
MFCD00001250 [MDL num­ber]
дитранол [Russ­ian] [INN]
ديثرانول [Ara­bic] [INN]
地蒽酚 [Chi­nese] [INN]
[1143-38-0]
1,8-dihydroxy-10H-anthracen-9-one
1,8-DIHY­DROXY-9,10-DIHY­DROAN­THRA­CEN-9-ONE
1,8-Dihydroxy-9-anthrane
1,8-DIHY­DROXY-9-ANTHRONE
480-22-8 [RN]
54035-94-8 [RN]
anthracene-1,8,9-triol
Anthra­derm [Trade name]
Anthra-Derm
Anthra­line
Anthrone, 1,8-dihydroxy-
Batidrol
Batri­dol
CCRIS 628
Chryso­der­mol
Cig­no­lin
Cigth­ra­nol
Dithra­nolum [INN-Latin]
DrithoCreme
Drithoscalp
Lasan
Prestwick_​528
Pso­dadrate
Pso­riacide
Psoriacid-Stift

SMILES

c1cc2c(c(c1)O)C(=O)c3c(cccc3O)C2

Std­InChI

InChI=1S/C14H10O3/c15-10-5-1-3-8-7-9-4-2-6-11(16)13(9)14(17)12(8)10/h1-6,15-16H,7H2

Std­InChIKey

NUZWLK­WWN­N­JH­PT-UHF­F­­FAOYSA-N

Mol­e­c­u­lar Formula

C14H10O3

Mol­e­c­u­lar Weight

226.227

EINECS

214-538-0

Beil­stein Reg­istry Number

2054360

MDL Number

MFCD00053409

Prop­er­ties

Appear­ance

Yel­low or brown­ish – yel­low, crys­talline powder 

Melt­ing Point

178° – 182°C

Safe­ty Data

Sym­bol

exclamation mark jpg - Dithranol CAS 1143-38-0GHS07

Sig­nal Word

Warn­ing

Haz­ard statements

H315-H319-H335

Pre­cau­tion­ary Statements

P261-P305 + P351P338

Per­son­al Pro­tec­tive Equipment

dust mask type N95 (US), Eye­shields, Gloves

RIDADR 

NONH for all modes of transport 

WGK Germany

3

RTECS

CB8927000

Spec­i­fi­ca­tions and Oth­er Infor­ma­tion of Our Dithra­nol CAS 1143-38-0

Assay

98.5 % – 101.0 %

Loss on Drying

≤0.5 %

Known Appli­ca­tion

Often used as a der­ma­tol­ogy for the treat­ment of psoriasis.

This prod­uct is devel­oped by our R&D com­pa­ny Cam­ing Phar­ma­ceu­ti­cal Ltd(http://​www​.cam​ing​.com/), and here is the cor­re­spond­ing linkhttp://​www​.cam​ing​.com/​d​i​t​h​r​a​n​o​l​-​c​a​s​-​1​1​4​3​-​3​8​-0/

Quick Inquiry

Fill out our inquiry form and one of our experts will be in touch with you short­ly (Please change screen to hor­i­zon­tal for com­plete brows­ing if you are check­ing Wat­son on your mobile phone). 

























    Please prove you are human by select­ing the house.